---

$1.47

-1.6100 ( -52.30% ) 254.2K

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Open	$1.47
Previous Close	$3.08
Volume	254.2K
Market Cap	$391.75M
Day Range	$1.22 - $1.72
52 Week Range	$1.22 - $4.98
Shares Outstanding	127.19M
Change %	-52.30%
Net Change	▼ -1.6100
Insider Ownership	-0.03%
Exchange	NYSE
Sector	Miscellaneous
Industry	None
IPO Year	2020
Country	United States
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-10-28	Buy	3846153.00	Redmile Group, LLC
2025-06-13	Buy	15734267.00	Redmile Group, LLC
2024-12-13	Buy	50000.00	Redmile Group, LLC
2024-07-03	Buy	400000.00	Redmile Group, LLC
2024-06-18	Sale	-6995.00	Sandor Victor
2024-06-18	Sale	-6995.00	BIZZARI JEAN-PIERRE
2024-06-18	Sale	-1437.00	Pfisterer Thomas
2024-06-18	Sale	-1437.00	Monges Viviane
2024-06-18	Sale	-1193.00	Hug Peter
2024-06-18	Sale	-6995.00	Azelby Robert